BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.1492, Ensuring Pathways to Innovation Cures (EPIC) Act Implementation of Inflation Reduction Act of 2022 ORPHAN Cures Act Discussions regarding H.R.1, One Big Beautiful Bill Act regarding bio-pharmaceutical provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| RODGER CURRIE New | — |
| JOHN DEOUDES | — |
| STEPHANIE A. DYSON | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
| PAUL ANTHONY WILLIAMS | — |
Medicare/Medicaid MMM
Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions Issues related to the six protected classes of medicines under Medicare Part D, regarding all bio-pharmaceutical issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| RODGER CURRIE New | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
Taxation/Internal Revenue Code TAX
Proposed policies regarding corporate tax reform - regarding all bio-pharmaceutical related provisions Discussions regarding OECD implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| JOHN DEOUDES | — |
| LANE PENRY | — |
Copyright/Patent/Trademark CPT
Intellectual Property Reform concerning bio-pharmaceutical industry
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| RODGER CURRIE New | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| LANE PENRY | — |
Pharmacy PHA
S.864, HELP Copays Act S.526, Pharmacy Benefit Manager Transparency Act of 2025 H.R.3285, Fairness for Patient Medications Act S.1339, Pharmacy Benefit Manager Reform Act Modernizing and Ensuring Equity Act H.R.3521, Clinical Trials Modernization Act Discussions regarding Continuing Resolution to include PBM reform, H.R.1968
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| JOHN DEOUDES | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| LANE PENRY | — |
Trade (domestic/foreign) TRD
International Reference Pricing/Most Favored Nation, including all bio-pharmaceutical issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| RODGER CURRIE New | — |
| JOHN DEOUDES | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| LANE PENRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.